Wang, Y.; Xu, N.; Ndzie Noah, M.L.; Chen, L.; Zhan, X.
Pyruvate Kinase M1/2 Proteoformics for Accurate Insights into Energy Metabolism Abnormity to Promote the Overall Management of Ovarian Cancer Towards Predictive, Preventive, and Personalized Medicine Approaches. Metabolites 2025, 15, 203.
https://doi.org/10.3390/metabo15030203
AMA Style
Wang Y, Xu N, Ndzie Noah ML, Chen L, Zhan X.
Pyruvate Kinase M1/2 Proteoformics for Accurate Insights into Energy Metabolism Abnormity to Promote the Overall Management of Ovarian Cancer Towards Predictive, Preventive, and Personalized Medicine Approaches. Metabolites. 2025; 15(3):203.
https://doi.org/10.3390/metabo15030203
Chicago/Turabian Style
Wang, Yan, Nuo Xu, Marie Louise Ndzie Noah, Liang Chen, and Xianquan Zhan.
2025. "Pyruvate Kinase M1/2 Proteoformics for Accurate Insights into Energy Metabolism Abnormity to Promote the Overall Management of Ovarian Cancer Towards Predictive, Preventive, and Personalized Medicine Approaches" Metabolites 15, no. 3: 203.
https://doi.org/10.3390/metabo15030203
APA Style
Wang, Y., Xu, N., Ndzie Noah, M. L., Chen, L., & Zhan, X.
(2025). Pyruvate Kinase M1/2 Proteoformics for Accurate Insights into Energy Metabolism Abnormity to Promote the Overall Management of Ovarian Cancer Towards Predictive, Preventive, and Personalized Medicine Approaches. Metabolites, 15(3), 203.
https://doi.org/10.3390/metabo15030203
